argenx SE (ARGX)
1011.29
-28.49
(-2.74%)
USD |
NASDAQ |
Aug 24, 16:00
1011.29
0.00 (0.00%)
After-Hours: 20:00
argenx Enterprise Value : 64.28B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 64.28B |
| August 20, 2026 | 64.17B |
| August 19, 2026 | 63.85B |
| August 18, 2026 | 61.38B |
| August 17, 2026 | 61.06B |
| August 14, 2026 | 52.61B |
| August 13, 2026 | 52.96B |
| August 12, 2026 | 54.14B |
| August 11, 2026 | 53.45B |
| August 10, 2026 | 53.53B |
| August 07, 2026 | 53.46B |
| August 06, 2026 | 54.10B |
| August 05, 2026 | 53.64B |
| August 04, 2026 | 52.19B |
| August 03, 2026 | 51.34B |
| July 31, 2026 | 52.77B |
| July 30, 2026 | 53.93B |
| July 29, 2026 | 54.55B |
| July 28, 2026 | 53.91B |
| July 27, 2026 | 54.94B |
| July 24, 2026 | 56.75B |
| July 23, 2026 | 57.15B |
| July 22, 2026 | 52.64B |
| July 21, 2026 | 54.06B |
| July 20, 2026 | 52.30B |
| Date | Value |
|---|---|
| July 17, 2026 | 53.19B |
| July 16, 2026 | 53.03B |
| July 15, 2026 | 53.33B |
| July 14, 2026 | 53.12B |
| July 13, 2026 | 54.16B |
| July 10, 2026 | 54.24B |
| July 09, 2026 | 56.21B |
| July 08, 2026 | 56.57B |
| July 07, 2026 | 56.86B |
| July 06, 2026 | 56.67B |
| July 02, 2026 | 58.08B |
| July 01, 2026 | 56.22B |
| June 30, 2026 | 57.35B |
| June 29, 2026 | 56.40B |
| June 26, 2026 | 54.83B |
| June 25, 2026 | 54.92B |
| June 24, 2026 | 52.69B |
| June 23, 2026 | 52.74B |
| June 22, 2026 | 55.86B |
| June 18, 2026 | 54.25B |
| June 17, 2026 | 55.15B |
| June 16, 2026 | 54.30B |
| June 15, 2026 | 54.65B |
| June 12, 2026 | 55.23B |
| June 11, 2026 | 55.56B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Autolus Therapeutics Plc | 806.14M |
| Akari Therapeutics Plc | 6.680M |
| Forte Biosciences, Inc. | 1.377B |
| Evaxion AS | 20.71M |
| Grifols SA | 14.00B |
Enterprise Value Related Metrics
| Earnings Yield | 2.59% |
| Operating Earnings Yield | 2.28% |
| Normalized Earnings Yield | 2.594 |